This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century.
| Serija: | Public Health Ethics Analysis |
| Leidėjas: | Springer Nature Switzerland |
| Išleidimo metai: | 2020 |
| Knygos puslapių skaičius: | 468 |
| ISBN-10: | 3030278735 |
| ISBN-13: | 9783030278731 |
| Formatas: | 241 x 160 x 31 mm. Knyga kietu viršeliu |
| Kalba: | Anglų |
Parašykite atsiliepimą apie „Ethics and Drug Resistance: Collective Responsibility for Global Public Health“
